Hope123
Senior Member
- Messages
- 1,266
Definitely my memory cannot add anything to this discussion. But I have this . . . question . . . quibble . . . about the above explanation.
1. I cannot imagine WPI was able to get four plus blood samples from each patient they tested. The two studies I've been involved with that are working with WPI have only requested one. Also, this has not been brought up with regards to the IC study — no one has said that their study may not be accurate because they didn't have blood from CFS patients drawn from four different occasions (although I think ? Judy mentioned that they should have run the tests more than the three standard times). I just cannot imagine any of the sources of the blood for the Science study had four samples from each patient. Nor do I think their Bio Bank contains four different samples from each patient.
2. If they had to test CFS patients from four different blood draws to be sure of their results, wouldn't they have had to test the controls blood from four different draws? How could they be sure the controls were negative without that?
So it's just not making sense to me. It seems rather that there is not usually a lot of XMRV in each sample — I cannot remember the quote here — so to test it multiple times will make it more likely for you to find that "needle in the haystack."
Just some thoughts. And because I don't trust my brain, they may be completely wrong thoughts, but they are my thoughts. I'm sticking to them.
1. I would not be surprised if they did have 3 or 4 samples from at least some people, esp. if they came out of Peterson's clinic since he has followed people for a long time. Like the other poster (sorry, forgot name), it's hard to tell if these patients were at their sickest or not. Sicker people may be more likely to see their doc but we all know how sometimes you're so sick and you know big changes aren't forthcoming from the doc visit that you just decide to stay home. It should be noted in the Defreitas study they also tested more than one blood sample from CFS subjects.
2. Good point.
3. Testing for HIV twice is a different matter.
A) If you are at high risk, sometimes antibodies to HIV do not show up immediately but 6 months later (the "window" period) so you can be infected but not be positive
on the test. So if you had sex with someone recently with HIV, you might need to get tested twice. That's also why people who are high risk should be regularly tested.
B) If the first test is positive, people are usually re-tested with a different test. THe first test is an antibody test; the second a Western Blot which looks at HIV proteins.
The second test is to confirm HIV presence.
(Note that WPI tested for XMRV PCR/culture/antibodies/Western Blot for Science article.)
4. If I heard correctly and progesterone stimulates XMRV, perhaps women should get tested more than 2 weeks after menstruation, when their progesterone levels are at the highest. Of course, this will be affected if they are on hormone therapy, have gyn issues, or are around menopause. WPI should look into this.
5. I liked that WPI made this talk public but they need to get this info out in a PUBLISHED articles and in complete form rather than dribs and drabs here and there. It's helpful for us but it doesn't present a good image to the scientific community. The history of CFS research is plagued by unpublished research (ala Cort's XMRV article) and poor public relations already.